Tuesday, March 21, 2017 8:44:30 AM
ATNM - 1.35 Pre-market now at 1.45/1.47
Actinium Pharmaceuticals Gets Positive Advice From Europe Drug Agency on Approval Pathway for Lomab-B
Actinium Pharmaceuticals Gets Positive Advice From Europe Drug Agency on Approval Pathway for Lomab-B
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
